Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort study

@Dr_RShatsky @ucsdim @UCSDMedSchool Good thread Dr Shatsky. In review of IV iron therapy, risks are infusion reactions in < 1% and hypophosphatemia. No evidence for infection. https://t.co/rnowbA6wth In ICU, hepcidin assoc with successful IV iron thera

@jes4bris @UKCCRGroup Papers from our group and @ed_litton https://t.co/lzUDWUAG45 https://t.co/QIHHrj47nx